More Awareness Needed of Heart Events Tied to Breast Cancer Drugs, Experts Say

(MedPage Today) -- Pharmacovigilance is needed to identify, monitor, and prevent cardiovascular adverse events (CV-AEs) associated with new agents for breast cancer and to reduce the risk of cardiotoxicity for the growing number of survivors, according...
Source: MedPage Today OB/GYN - Category: OBGYN Source Type: news